Biophotonic probes for bio-detection and imaging

 The rapid development of biophotonics and biomedical sciences makes a high demand on photonic structures to be interfaced with biological systems that are capable of manipulating light at small scales for sensitive detection of biological signals and precise imaging of cellular structures. However, conventional photonic structures based on artificial materials (either inorganic or toxic organic) inevitably show incompatibility and invasiveness when interfacing with biological systems.

The design of biophotonic probes from the abundant natural materials, particularly biological entities such as virus, cells and tissues, with the capability of multifunctional light manipulation at target sites greatly increases the biocompatibility and minimizes the invasiveness to biological microenvironment. In this review, advances in biophotonic probes for bio-detection and imaging are reviewed. We emphatically and systematically describe biological entities-based photonic probes that offer appropriate optical properties, biocompatibility, and biodegradability with different optical functions from light generation, to light transportation and light modulation.

Three representative biophotonic probes, i.e., biological lasers, cell-based biophotonic waveguides and bio-microlenses, are reviewed with applications for bio-detection and imaging. Finally, perspectives on future opportunities and potential improvements of biophotonic probes are also provided.Sensitive detection of biological signals and precise observation of pathological changes are of great importance for the early diagnosis and treatment of infectious diseases, cancer, and other health disorders. However, owing to the low quantity of biochemical signals and complex microenvironment in biological systems, the detection of the targets of interest is challenging. Fortunately, the prosperous development of optical and photonic technologies in recent years provides many choices for optical detection and imaging, holding great promises for real-time visualization of biological signals in complex biological structures and processes.

Optical detection exploits optical responses, such as light absorption, scattering, fluorescence, and reflectance, induced by biophysical/biochemical changes for bio-identification and disease diagnosis3. Due to the inherently label-free nature, optical detection is a powerful alternative to conventional detection techniques (e.g., mass or electrochemical)With optical detection techniques, real-time signals of a wide range of biological test samples (from molecular biomarkers to pathogens and cells, and even to tissues and organs) can be obtained in a non-invasive manner with high-sensitivity and high-resolution To date, optical detection and imaging have been demonstrated to be one of the most powerful technologies for detection of biological signals and for diagnosis .

For a precise and flexible optical detection in a biological microenvironment, photonic probes with micro/nanostructures are always desirable. For this purpose, the selection of appropriate optical materials is certainly crucial, since the probing performance largely depends on their chemical and mechanical properties, optical functionalities as well as biological performances.

To date, the most commonly used materials for the assembly of versatile photonic components and photonic probes are mainly based on inorganic materials such as silica glass, or organic polymers such as polymer nanowires. Because of their excellent optical properties, such as high transparency and suitable mechanical strength, these materials have been applied for nanophotonic integrated devices in diversified fields of application. For example, optical waveguides based on silica optical fibers have been widely studied and were even used for implantations in animal bodies, particularly fiber-optic implants in the brain for optogenetic studies.

 However, the main disadvantage of these photonic components based on traditional materials is low biocompatibility and biodegradability, which greatly limit their potential in biomedical applications. High biocompatibility of a material is a fundamental requirement for in vivo applications, which demands the absence of toxicity and low health threat to the living systems29. Moreover, high biocompatibility also refers to the biofunctionalities that the implants can perform their expected functions in vivo. Additionally, biodegradability is another essential requirement, since the materials can be degraded and metabolized by the body without the need for additional operations to remove the implants.

With abundant natural biomaterials and biological entities, Mother Nature always inspire us to design photonic structures and probes to manipulate light. Indeed, living cells and microscopic organisms as well as their derivates such as DNA, proteins, silk and cellulose et al., show different capabilities to interact with light, and can further serve as different photonics devices such as waveguides, microlenses, gratings, and even lasers. These natural biomaterials and biological entities hold huge promise for creation of new photonic probes for bio-detection, imaging, and therapeutic applications.

They inherently possess excellent biological performances, including noninvasiveness, high biocompatibility, biodegradability, and resorbability. Moreover, another interesting feature of biological entities such as virus, cells and tissues is their ability to serve simultaneously as optical devices and diagnostic specimen, which facilitate further real-time detection and imaging in biocompatible microenvironments.

Therefore, instead of bio-derived materials and biomolecules (such as proteins and nucleic acids), biophotonic probes introduced in this review are mainly focused on large biological entities, such as virus, bacteria, fungi, algae, mammalian cells and tissues. By translating biological principles into man-made designs, these biophotonic probes offer a seamless interface between optical and biological worlds.

World Biophotonics Research Awards
Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee 

Internationally Renowned Biophotonics Researcher Secures Award to Develop New Medical Diagnostics and Treatment Tools

 Professor Stefan Andersson-Engels has been awarded €5.3 million through the SFI Research Professorship Programme, which will underpin the Biophotonics Group at Tyndall National Institute for the next five years. The funding will be used to advance the fundamental understanding of biophotonics science, the application of light-based technologies to life sciences and medicine.

This award will foster the development of new diagnostic and guidance tools to meet proven clinical needs. These will be implemented in the clinical setting of neonatology, neurosurgery, orthopaedics, and the GI tract, as well as oral cancer screening, and will be guided by 20 clinical and pre-clinical collaborators. The award aims to provide better healthcare and outcomes for patients, and to grow economic activity through the commercialisation of the resulting technologies. This will be achieved through partnerships with existing MedTech companies.

Principal Investigator at the IPIC SFI Research Centre for Photonics, Prof Andersson-Engels and his team have already created two start-up companies, one of which was in partnership with the National Cancer Centre in the Netherlands. The team has also transferred technologies to companies in the areas of cancer boundary detection and the monitoring of babies during childbirth.

The objective of Prof Andersson-Engels’ project is to use the unique properties of light, a safe, non-invasive method for humans that can accurately detect specific cells, for diagnostic purposes such as gastrointestinal diagnostics for malignancies and inflammatory bowel diseases, in-vivo oral cancer delineation and diagnosis. As light can only penetrate short distances into tissue, Prof Andersson-Engels will seek to address this challenge, and aim to facilitate light-based diagnostics and therapy deep inside the body, permitting use for many more diseases.  

Commenting on the award, Prof Andersson-Engels said: “I am delighted to be continuing our important work with the talented team across Tyndall, UCC, and IPIC. With the medical devices sector in Ireland recognised as one of the five emerging global hubs, it is an exciting time for the Biophotonics Group to forge close collaborations with companies, clinicians and research centres for the faster development and deployment of more accurate, less invasive diagnostic treatment methods for cancer and other diseases.”

Prof Andersson-Engels has an impressive track record, receiving several prizes for his research achievements, and his work on the development and commercialisation of technology has been critical to ensuring that patients will benefit from the results of scientific research. His pioneering work in the area of ALA-PDT (Photodynamic therapy) using the topical application of aminolevulinic acid (ALA), a photosensitizing agent for the treatment of non–melanoma skin cancer is currently one of the first lines of treatment at most skin cancer clinics around the world.

Welcoming the announcement, Deputy Director General of Science Foundation Ireland, Dr Ciarán Seoighe, said: “Recruiting and retaining world-leading scientific talent to Ireland is a key priority for SFI in partnership with our higher education institutions. Prof Andersson-Engels’ exceptional international track record will help to drive Ireland’s position at the forefront of photonics research. His work will contribute to improving the health and wellbeing of people by the invention and application of new technologies, as well as boosting industry engagement. We wish him every success with his research programme."

Surgical Oncologist, Head of Medical Affairs and Research, Centre for Early Cancer Detection at The Netherlands Cancer Institute, Professor Theo Ruers said: “We at The Netherlands Cancer Institute, have established a very strong and fruitful collaboration with the Biophotonics@Tyndall team over the last few years throughout the first phase of the Professorship Award. Our complementary skill sets have led to a spin-off company, multiple publications, and patents as well as collectively attracting EU and Health Holland funding. This collaboration is a win-win for both parties, and we expect the coming phase to be even more productive and impactful.”

Director of IPIC, the SFI Research Centre for Photonics, Professor Paul Townsend concluded: “This award further strengthens IPIC’s outstanding research team by providing the scientific vision and knowledge to steer existing photonic device integration towards innovative new applications in the biomedical areas. Furthermore, by continuing this world-class biophotonics research programme at IPIC and Tyndall, we can underpin strong collaborative partnerships with other Science Foundation Ireland Research Centres through projects that will present huge opportunities at a global level and again raise Ireland’s research credentials in the biomedical space.”

World Biophotonics Research Awards
Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee 

Advances in biophotonic sensors: Revolutionizing medical diagnostics and research

 Biophotonic sensors and systems are optical devices developed to deliver point-of-care diagnostics for medical practitioners and health researchers. They allow researchers to detect, sense, identify, and understand biological systems at the cellular/subcellular level, allowing them to gain a deeper understanding of biological processes, conditions, and molecular changes.

Biophotonics is an emerging field demonstrating rapid growth, and optical designers and researchers are persistently developing new ways of capturing high-quality imaging, increased sensitivity detection, and more detailed analysis. Photonics technologies power medical advances like disease diagnosis, food and water safety, and drug efficacy testing. This article presents examples of biophotonic breakthroughs and how they are already making a difference across medical diagnostics and research.

Lab-on-a-chip point-of-care biophotonic sensors

Low-cost point-of-care biosensors that can deliver laboratory-quality results within minutes are making it possible to diagnose a disease early on and efficiently. This eliminates the need for expensive laboratory equipment, prolonged waiting times, and large laboratories.

For example, the lab-on-a-chip biosensors developed in response to the global COVID-19 pandemic helped combat the virus. The early spread of the disease was, in part, a result of inefficient testing protocols, and health researchers across the world worked hard to find a quick, reliable way to determine the presence of the virus.

One such way turned out to be a SARS-CoV-2 specific immunoglobulin G biophotonic sensor, which employed biofunctionalization to detect specific COVID-19 antibody selectivity. The sensors can be produced directly on the face of a single fiber optic, a single-mode fiber-28, and are sensitive enough to identify whether antibodies are present in a sample in around one minute’s time.

Optical coherence tomography (OCT) in dermatology

Previously, medical practitioners had to perform a biopsy to determine the presence of malignant tissue on the skin, but current optical coherence tomography technologies allow for a rapid, simple diagnosis without any skin excision. It can image skin to a depth of 2 mm, and resolution can be between 15 and 3 μm.

Biophotonics can also be employed during surgery to ensure full removal of problematic tissue. Nanoparticles functionalized with fluorescent dyes are applied to the skin to assemble in a particular kind of tissue. Any malignant tissue will glow when the skin is exposed to the relevant wavelengths of dye. This allows the surgeon to use epifluorescent microscopy and optical detection to decide what needs to be removed and what can be left. 

AI and biophotonic analysis

Deep learning algorithms are key for natural language processing and humanoid chatbots, and they are also central to how biophotonic data is processed. Just as machines can learn to comprehend human language, they can also learn to read the fingerprints of cells, organelles, and molecules. This enables the automation of basic diagnostics, and verification steps can be programmed into the system to ensure that nothing goes awry. 

At times, label-free identification of biological compounds will require analysis of a complex spectrum, which can be achieved by feed-forward neural networks (multilayer perceptrons, MLP) or recurrent neural networks (RNNs). These neural networks can compare test spectrums with detailed cataloged records to predict the probability of abnormal growths, disease, or the presence of other molecules. 

Deep learning algorithms can also conduct matrix multiplication containing millions of parameters, resolving complex equations that enable denoising, semantic segmentation, disease recognition, and even pseudostaining. Every day, breakthroughs in AI technologies are accelerating processing techniques and the potential of these analytical methods. 

Examples of advances in machine learning and biophotonics include AI solutions that can pull from extensive imaging data libraries to automatically detect the signs of infection in the inner ear. The AI-powered software can evaluate an OCT image of the ear captured by a portable device within half a minute. The data is then translated for diagnosis just as an expert would. 

Another example of AI in real-world applications is an intraoperative diagnosis system using stain-free, slide-free multimodal multi-photon microscopy. The data-rich images captured by biophotonic technology usually take a very long time to evaluate manually, but an AI system can generate a reliable, verifiable diagnosis in just a few minutes. 

Avantier is at the forefront of pushing the scientific envelope with advances in biophotonics. If you need a custom optical component, Avantier can manufacture exactly what you need, and a team of optical designers is on hand to help you determine what configurations will be optimally suited for your system. 

World Biophotonics Research Awards
Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee 

Biophotonic (nano)structures: from fundamentals to emerging applications

 Biophotonics is a dynamic interdisciplinary field that merges biology, photonics, and optics to explore and manipulate biological systems through light. Its applications are particularly prominent in medical diagnostics, imaging, and therapy. Key uses of biophotonic (nano)structures include enhancing medical imaging and enabling biosensing to detect disease markers. In therapeutic contexts, these nanostructures show significant promise in photothermal and photodynamic therapies, improving imaging contrast and allowing for real-time monitoring of cellular processes. However, the field faces challenges such as fabrication complexities, scalability, biocompatibility, and integration with existing technologies.

For instance, limited biocompatibility can lead to adverse immune responses or toxicity, hindering their safe use in vivo, while scalability issues restrict the mass production of nanostructures with consistent quality, both of which are critical for clinical translation. Moreover, integrating these materials with existing medical devices or workflows often requires redesigning current platforms, slowing down adoption. Despite these obstacles, the future of biophotonics appears promising, especially with advancements in nanotechnology, including 3D printing and self-assembly, which could streamline production.

The potential integration of biophotonic nanostructures with emerging technologies like wearable devices and point-of-care diagnostics could revolutionize healthcare by facilitating continuous health monitoring and rapid disease detection. This review aims to provide a thorough examination of biophotonic nanostructures and their emerging applications in disease diagnosis, imaging, and therapy. Additionally, it will address the challenges and future directions of biophotonic research, enhancing our understanding of how these innovative technologies can tackle critical issues in modern medicine and deepen our knowledge of complex biological systems.

The purpose of this review is to explore the fundamentals, challenges, and future perspectives of biophotonic (nano)structures, highlighting their emerging applications and potential advancements.

Despite these advancements, several limitations remain in the development and application of biophotonic nanostructures. One major challenge is the scalability and cost-effectiveness of nanomaterial synthesis, particularly for clinical translation. Ensuring long-term biocompatibility and stability of biophotonic devices in complex biological environments is another critical issue. Indeed, the limited biocompatibility and biodegradability of these materials pose challenges for in vivo applications. Moreover, the integration of these devices into existing medical workflows requires standardized protocols and rigorous validation.35 Recent innovations in material science and device fabrication have addressed some of these challenges. For instance, researchers have explored naturally derived biomaterials, such as DNA, proteins, silk, and polysaccharides, which exhibit remarkable optical properties, biological compatibility, and degradability.

Green fluorescent protein (GFP) and riboflavin have been employed as gain media in biological lasers, while silk-based photonic structures have demonstrated potential for creating biocompatible optical devices.

The integration of biophotonic nanostructures with biological entities, such as cells, viruses, and tissues, has opened new avenues for designing hybrid systems.

These bio-inspired and biologically derived materials enable the construction of photonic devices that seamlessly interface with living systems, enhancing their functionality and adaptability for biomedical applications.

The development of self-assembled nanostructures and 3D-printed biocompatible materials has paved the way for scalable and customizable biophotonic devices. Hybrid systems that combine plasmonic NPs with responsive polymers offer tunable optical properties, enhancing their functionality for targeted diagnostics and therapy.

The aim of this review is to provide an overview about the recent advancements and emerging applications of biophotonic nanostructures via focusing on their applications in disease diagnosis, imaging, and therapy.

To this aim, the integration of biophotonic nanostructures in optoelectronics has been explored via highlighting their contributions to light-emitting diodes (LEDs), photodetectors, and other photonic devices. Furthermore, the challenges associated with their design, synthesis, and clinical translation have been discussed, offering insights into potential future directions for this rapidly evolving field. By bridging the gap between photonics, biology, and materials science, biophotonic nanostructures hold immense potential for developing healthcare and advancing our understanding of complex biological systems. Through this review, we aim to highlight the transformative impact of these nanostructures on science and technology, emphasizing their role in addressing some of the most pressing challenges in modern medicine.


World Biophotonics Research Awards
Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee 

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Society Awards

SPIE Announces Its 2026 Society Awards — Recognizing Excellence Across Optics & Photonics

SPIE, the International Society for Optics and Photonics, has revealed the winners of its prestigious 2026 Society Awards, honoring outstanding contributors to research, engineering, education, and community leadership in light-based science and technology. These annual honors celebrate both technical breakthroughs and sustained service to the global optics and photonics community — reinforcing SPIE’s role as a key advocate for innovation in fields from biomedical imaging to astronomical instrumentation.

The SPIE Gold Medal, the Society’s highest accolade, was awarded to Maryellen Giger for her pioneering work in computer-aided diagnosis and image analysis, significant influence on clinical translation, and mentorship of emerging medical-imaging scientists. Other major awardees include leaders in optical fabrication, scientific publishing, advanced light sources, and diversity outreach — illustrating the breadth of impact across both academic and industrial sectors.

Among other notable recognitions:

• The SPIE President’s Award acknowledged visionary leadership and service to optics education.

• The SPIE Mozi Award highlighted innovation in light sources with broad applications.

• Honors in biomedical optics, optical metrology, diffractive optics, and lithography underscored contributions to both fundamental science and enabling technologies.

• Early career and diversity outreach awards emphasized the Society’s commitment to fostering future talent and inclusive participation.

SPIE’s awards complement the broader community’s recognition efforts: 40 new SPIE Fellows were inducted in 2026, signifying exceptional technical achievement and professional contribution across optics and photonics disciplines. These Fellows — selected from leading academic, industry, and government institutions worldwide — illustrate the Society’s global reach and interdisciplinary impact.

Broader SPIE Community Activities and Awards

The Society’s awards are part of a wider landscape of recognition within the optics and photonics field:

• SPIE Prism Awards: Finalists in the 2026 Prism Awards — which spotlight commercialized innovations in photonics — include technologies spanning biophotonic instruments, quantum tech, lasers, and sensors. Winners will be celebrated at SPIE Photonics West in January 2026, showcasing products that are transforming markets from medical devices to advanced imaging systems.

• SPIE Startup Challenge: Earlier announcement of finalists for the 2026 SPIE Startup Challenge highlights early-stage companies with investable optics and photonics technologies — a key platform for translating research into commercial impact.
  
  

  Why SPIE Awards Matter

  As one of the most influential professional societies in light-based sciences and engineering, SPIE’s annual awards bring visibility to high-impact research, promote collaboration between academia and industry, and help shape the future of technologies driven by optics and photonics — from healthcare and manufacturing to communications and environmental sensing. Recognition by SPIE often reflects not only scientific excellence but also sustained commitment to community building and mentorship across generations of researchers and professionals.
  
  
  World Biophotonics Research Awards
  Visit: biophotonicsresearch.com
  Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee 

 

Clinical advantages of biophotonics

 Biophotonics is a branch of science dealing with the interaction of light in biological substances such as tissues and cells at scales ranging from microns to the nano-level. It plays a vital role in the development of healthcare services by lowering the costs of treatment, with a suitable methodology for treatment of people in the aging society. Biophotonics consists of optics, photonics, nanotechnology, and biotechnology.Clinical biophotonics are also termed as therapeutic biophotonics, because the whole process deals only with therapeutic measures to treat diseases and to alter the biological processes using high energized optical radiations.

Clinical advantages of biophotonics

Precision

Instruments like laser scanning systems, optical coherence tomography, and laser polarimetry are used to acquire precise knowledge of retinal tissues and vessels.   

Photo-ablation

The photo-ablation effect of lasers is helpful in the process of laser osteotomy. This property of lasers can be used to perform operations that cause less damage to the internal and surrounding tissues and also provide good control on the depth of cut.

Sensor controlled laser systems:

Sensor controlled laser systems play a major role in the field of clinical treatments. They are involved in investigational tests of living tissues in animals and humans. Sensor combined laser sources are also used in treatment of malignant tissues in order to perform specific excision of the infected tissue in an efficient and safe way. This method is also used for removal of tumor tissues and intraluminal calculi.

Reduced treatments and time

The use of laser has the benefit of radiation transportation. Incident radiation from a laser source can be transferred using thin flexible optical fibers into the body endoscopically via natural body openings and small surgical cuts. Hence, the process of conventional surgery that requires larger incisions is replaced by laser endoscopic surgery to reduce the patient’s surgical pain. The time required for potential surgical treatment is reduced to a level equal to the time spent on treatment of outpatients.

Clinical applications of biophotonics

Laser processing of tissues

Laser tissue processing methods such as incision, coagulation, and excision follow various laser–tissue interaction procedures. These are involved as clinical measures in various medical fields such as ophthalmology, gynecology, urology, dentistry, and surgery of ear, nose, and throat. Intense control over the laser systems enhance the performance of treatments with high precision and also help to avoid harmful effects to the nearby tissues.

Nowadays, laser treatments are mainly opted for because the incision and excision process takes place at very high temperature and, therefore, the tiny blood vessels and slits in the nerve-endings get solidified and lead to reduced loss of blood and surgical trauma.

Photodynamic therapy (PDT)

Photodynamic therapy is one of the major applications of biophotonics. PDT consists of three components: photosensitizer (light sensitive chemical that can be energized by light of a specific wavelength), light source, and tissue oxygen. In this treatment, patients are given a photosensitizer chemical and then the excitation light is irradiated on them by the surgeon.

Various diseases that are treated with PDT are as follows:

• Non-malignant diseases such as ophthalmic disease, cardiovascular disease, dermatological disease, and urological disease.
• Malignant diseases such as brain tumor, head and neck cancer, ophthalmic tumor, pulmonary and pleural mesothelial cancer, breast cancer, gastroenterological cancer, urological cancer, gynecological cancer, and skin pre-malignant and malignant diseases.
• Oral problems

Refractive cataract surgery

Femtosecond laser (FSL) cataract surgery is a recent technique developed in the field of ophthalmology with improved stability and predictableness in corneal incisions and anterior capsulorhexis. It involves the use of excimer and femtosecond lasers for treatment of refractive errors. It allows successively less phacoemulsification energy and time required, which results in reduced corneal edema. FSL allows complexity of the anterior capsulotomy, intraocular lens (IOL) placement, capsule overlap, and centration of the IOL. Further advancement in these methods will enhance the treatment of myopia, hypermetropia, and astigmatism.

Opto-mechanical stimulation

Artificial vision in humans can be achieved by opto-mechanical stimulation that provides vision for patients with ocular blindness. In this process, optical chips are embedded in the sub-retinal space that permits supplementation of the ocular path. Future developments in this process include stimulation of the optical cortex with electrical signals from video systems that can replace the working of the eyes and provide artificial vision.

Near-infrared (NIR) phototherapy

This process involves clinical treatment using light with wavelength near or equal to the infrared light in the spectrum band. NIR radiation enables wound healing, supports muscle repair, and promotes angiogenesis. It is employed in various conditions such as skin ulcers, osteoarthritis, peripheral nerve injury, low back pain, myocardial infarction, and stem cell induction. Light emitting diodes (LED) can reduce pain and stimulate wound healing in patients who have undergone bone marrow transplantation.

Research on clinical biophotonics is heavily focused on invention of more efficient drugs that enable far/near infrared wavelength activation, so that increased volumes can be treated under surface illumination.

World Biophotonics Research Awards
Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Dogs' noses decoded: Optical sensor unveils canine brain's olfactory prowess

 A pioneering study investigating the brain activity of dogs during scent detection has unveiled crucial insights into their remarkable olfactory capabilities. Researchers at Bar-Ilan University have developed an optical sensor capable of remote sensing dogs' brain activity in three key regions—the olfactory bulb, hippocampus, and amygdala—that play a critical role in how dogs distinguish between different smells. This breakthrough could lead to the development of a compact, non-invasive device capable of interpreting and translating a dog's olfactory perceptions for human understanding.

In the study published in the Journal of Biophotonics, scientists employed a cutting-edge detection structure system using laser technology and a high-resolution camera to capture brain activity in real-time from four dog breeds.

These dogs were exposed to four distinct scent stimuli—garlic, menthol, alcohol, and marijuana. The data were then analyzed using a machine-learning algorithm revealing that the amygdala plays a significant role in scent differentiation, highlighting the emotional and memory-related aspects of odor processing.

"The findings show that the amygdala is crucial in the way dogs process and react to odors, with specific scents triggering distinct emotional and memory responses, and we are capable of optically detecting their brain activity in this region," said Prof. Zeev Zalevsky, from the Kofkin Faculty of Engineering at Bar-Ilan University. "This discovery could be the first step toward creating a device that enables us to better understand and interpret the unique way dogs perceive and differentiate smells."

The study introduces an innovative method of brain activity analysis through laser-based speckle pattern detection, a remote, non-invasive technique that has never been applied to canine brain activity. Unlike traditional methods such as fMRI or EEG, this approach allows researchers to observe brain responses without requiring the dog to be sedated or confined to bulky equipment. This opens up new possibilities for studying dogs in real-world environments, making the technique both affordable and accessible for further research.

Dogs have long been celebrated for their exceptional sense of smell, and this research further illuminates the advanced processes that occur in their brains when detecting odors. With an olfactory system far more developed than humans, dogs can detect a broader range of odors, with specialized receptors in their noses that allow them to process and distinguish even the faintest scents.

This new research offers a glimpse into the intricate workings of the canine brain as it processes different smells, presenting a promising avenue for future applications in areas such as drug detection, medical diagnostics, and search-and-rescue missions.

"Our next step is to develop a portable, Wi-Fi-controlled device equipped with a mini camera and laser system, which could be mounted on a dog's head and used to monitor its olfactory responses in real time," said Dr. Yafim Beiderman from Prof. Zalevsky's Optical Research Lab at Bar-Ilan University.

"This could significantly enhance the way dogs are used in scent detection, from detecting illegal substances to diagnosing diseases in humans, all while deepening our understanding of how they perceive the world around them. More importantly, this real-time sensing could bypass the need to train dogs to utilize their scent abilities."

The implications of this research could also revolutionize the way dogs are utilized in law enforcement, health care, and beyond. As dogs continue to be invaluable partners in scent detection, this device could provide a means of translating their highly specialized abilities into data that is useful for humans, fostering a stronger connection between the two species.

Bio Photonics Research Award

Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee